|Articles|January 18, 2022
High Salt—High Reproducibility
Author(s)Agilent
Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Next-Generation Modalities Drive New Antibody Discovery
3
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5